Blood cancer Clinical Trials in Commack, NY
As of August 2026, 41 paid clinical trials are recruiting for Blood cancer in Commack, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
41 clinical trials for Blood cancer
·Clear filters·A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
A Study of CRD3874-SI in People With Leukemia
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A Study of Revumenib and Mezigdomide in People With Leukemia
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
A Dietary Study for People With Multiple Myeloma
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Top Research Study Locations in Commack
Researchers run research studies in Commack, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Commack | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Breast Cancer | 65 |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Multiple Myeloma, Breast Cancer, Glioma | 39 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Non-Small Cell Lung Cancer, Breast Cancer, Anastomotic Leak | 17 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Breast Cancer, Prostate Cancer, Adenocarcinoma of the Breast | 15 |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | Acute Myeloid Leukemia, Bladder Cancer, Brain Tumor | 14 |
| Memorial Sloan Kettering Commack (Limited Protocol Activities) | Breast Cancer, Metastatic Breast Cancer, Brain Tumor | 11 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) | Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer | 10 |
| Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) | Gastric Adenocarcinoma, Gastric Cancer, Caregiver Burden | 9 |
| MSK Commack | Multiple Myeloma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 8 |
| Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) | Cancer, Bladder Cancer, Breast Cancer | 8 |
| Memorial Sloan Kettering Suffolk-Commack (Consent only) | High-risk Neuroblastoma, Metastatic Neuroblastoma, Neuroblastoma | 7 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) | Acute Myeloid Leukemia, AML, Acute Leukemia | 6 |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) | Metastatic Breast Cancer, Bone Sarcoma, Breast Cancer | 6 |
| True North Neurology | Migraine, Acute Migraine, Acute Treatment of Migraine | 6 |
| Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities) | Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Metastatic Renal Cell Carcinoma | 5 |
| Memorial Sloan Kettering Suffolk - Commack | Brain Metastases, Brain Metastases, Adult, Lung Cancer | 5 |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Endometrial Cancer, Non-Muscle Invasive Bladder Cancer, Non-Small Cell Lung Cancer | 5 |
| Memorial Sloan Kettering Cancer Center @ Commack | Colorectal Cancer, Colorectal Carcinoma, Hodgkin Lymphoma | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) | Alveolar Soft Part Sarcoma, Extramammary Paget's Disease, Multiple Myeloma | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Cancer | 4 |
| Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) | Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV | 4 |
| Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) | CNS Metastases, Central Nervous System Metastasis, Metastasis | 4 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) | HNSCC, Head Cancer, Head Cancer Neck | 4 |
| Memorial Sloan Kettering Commack (All Protocol Activities) | Endometrial Cancer, Endometrial Cancer Stage I, Endometrioid Adenocarcinoma | 4 |
| Memorial Sloan Kettering Commack (Consent Only) | Adolescents and Young Adults With Cancer, Radiation Therapy, Breast Cancer | 4 |
Active & Upcoming Studies in Commack (2026)
Recruiting trials in Commack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (254 active studies)
- A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate · Phase 1 · Memorial Sloan Kettering Cancer Center
- A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · Phase 2 · Memorial Sloan Kettering Cancer Center
Neurology & pain (9 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Pediatric (2 active studies)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Vaccines (1 active study)
HIV / STI (1 active study)
- A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma · Phase 2 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Commack
- Breast Cancer (28 active studies)
- Multiple Myeloma (14 active studies)
- Prostate Cancer (12 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Endometrial Cancer (10 active studies)
- Non-Small Cell Lung Cancer (9 active studies)
Leading research sponsors in Commack
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Commack?
There are approximately 322 recruiting clinical trials in Commack, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Commack pay participants?
Most recruiting trials in Commack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Commack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Commack?
The most common conditions under active study in Commack include Breast Cancer (28), Multiple Myeloma (14), Prostate Cancer (12), Acute Myeloid Leukemia (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Commack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Commack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Commack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Commack?
Recruiting research sites in Commack include Memorial Sloan Kettering Commack, Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Commack right now?
The largest active categories in Commack are Cancer & tumors (254), Neurology & pain (9), Pediatric (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.